Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Beta-hydroxydehydrogenase deficiency is a rare genetic disorder that affects the body's ability to break down certain fats. It is caused by a mutation in the gene that codes for the enzyme beta-hydroxydehydrogenase, which is responsible for breaking down long-chain fatty acids. Without this enzyme, the body is unable to properly metabolize these fats, leading to a buildup of toxic byproducts in the body. Symptoms of this disorder can include seizures, developmental delays, and movement disorders. Treatment typically involves dietary changes and supplementation with medium-chain fatty acids, which can be metabolized without the need for beta-hydroxydehydrogenase.
All of the following must be considered when interpreting
clinical findings and are too extensive to be covered on
this site: